InvestorsHub Logo
icon url

Lemoncat

01/18/21 10:27 AM

#340418 RE: To infinity and beyond! #340417

That's why we're valued around $80M instead of $800M. There doesn't appear to be a clear answer. Higher risk, higher reward.

Go IPIX!
Go Bidencidin!
icon url

olden_grumpini

01/18/21 10:40 AM

#340421 RE: To infinity and beyond! #340417

UC needs long-term clinical trials. The Celgene therapy, ozanimod, took 5 years to complete their P3 for UC (Safety and Efficacy Trial of RPC1063 for Moderate to Severe Ulcerative Colitis). They had 372 study locations! Their P2 took 2 years.

My opinion is that UC is unrealistic for IPIX to pursue unless brilacidin has success against COVID. I'm basically of the mind that brilacidin for COVID is IPIX's last shot.
icon url

bradfordbros

01/18/21 11:21 AM

#340423 RE: To infinity and beyond! #340417

Surely it’s going to infinity and beyond. That’s your target isn’t it or don’t you believe you either?